These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 34339040)

  • 1. SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies.
    Almehdi AM; Khoder G; Alchakee AS; Alsayyid AT; Sarg NH; Soliman SSM
    Infection; 2021 Oct; 49(5):855-876. PubMed ID: 34339040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects.
    Arashkia A; Jalilvand S; Mohajel N; Afchangi A; Azadmanesh K; Salehi-Vaziri M; Fazlalipour M; Pouriayevali MH; Jalali T; Mousavi Nasab SD; Roohvand F; Shoja Z;
    Rev Med Virol; 2021 May; 31(3):e2183. PubMed ID: 33594794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
    Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
    Elife; 2020 Oct; 9():. PubMed ID: 33112236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play.
    Souza PFN; Mesquita FP; Amaral JL; Landim PGC; Lima KRP; Costa MB; Farias IR; Lima LB; Montenegro RC
    Int J Biol Macromol; 2021 May; 179():1-19. PubMed ID: 33667553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.
    Kim Y; Gaudreault NN; Meekins DA; Perera KD; Bold D; Trujillo JD; Morozov I; McDowell CD; Chang KO; Richt JA
    Microbiol Spectr; 2022 Jun; 10(3):e0178921. PubMed ID: 35638818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein.
    Zhang S; Go EP; Ding H; Anang S; Kappes JC; Desaire H; Sodroski JG
    J Virol; 2022 Feb; 96(3):e0162621. PubMed ID: 34817202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key mutations in the spike protein of SARS-CoV-2 affecting neutralization resistance and viral internalization.
    Wang Q; Ye SB; Zhou ZJ; Song AL; Zhu X; Peng JM; Liang RM; Yang CH; Yu XW; Huang X; Yu J; Qiu Y; Ge XY
    J Med Virol; 2023 Jan; 95(1):e28407. PubMed ID: 36519597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling coronavirus spike protein dynamics: implications for immunogenicity and immune escape.
    Kunkel G; Madani M; White SJ; Verardi PH; Tarakanova A
    Biophys J; 2021 Dec; 120(24):5592-5618. PubMed ID: 34767789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein.
    Yao Z; Zhang L; Duan Y; Tang X; Lu J
    J Infect; 2024 Mar; 88(3):106121. PubMed ID: 38367704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens.
    Duan L; Zheng Q; Zhang H; Niu Y; Lou Y; Wang H
    Front Immunol; 2020; 11():576622. PubMed ID: 33117378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of the SARS-CoV-2 genome and spike protein in the immunopathogenesis of COVID-19 and in the efficacy of vaccines.
    Jiménez-Morales S; Pérez-Amado CJ; Montúfar-Robles I; Fragoso JM; Aranda-Uribe IS; Ramos-Puga DA; Martínez-Flores ÁE; Ramírez-Bello J
    Cir Cir; 2023; 91(2):268-276. PubMed ID: 37084305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies.
    Papageorgiou AC; Mohsin I
    Cells; 2020 Oct; 9(11):. PubMed ID: 33105869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
    Jia Z; Gong W
    J Korean Med Sci; 2021 May; 36(18):e124. PubMed ID: 33975397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics.
    Yesudhas D; Srivastava A; Gromiha MM
    Infection; 2021 Apr; 49(2):199-213. PubMed ID: 32886331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
    Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
    Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Coronavirus Entry
    Outlaw VK; Bovier FT; Mears MC; Cajimat MN; Zhu Y; Lin MJ; Addetia A; Lieberman NAP; Peddu V; Xie X; Shi PY; Greninger AL; Gellman SH; Bente DA; Moscona A; Porotto M
    mBio; 2020 Oct; 11(5):. PubMed ID: 33082259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development.
    Khalaj-Hedayati A
    J Immunol Res; 2020; 2020():7201752. PubMed ID: 32695833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.